Please login to the form below

Not currently logged in
Email:
Password:

iniparib

This page shows the latest iniparib news and features for those working in and with pharma, biotech and healthcare.

AZ's Lynparza cleared for ovarian cancer in Europe

AZ's Lynparza cleared for ovarian cancer in Europe

Sanofi was forced to abandon development of its iniparib candidate, which had been in trials for breast and non-small cell lung cancer (NSCLC).

Latest news

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....